Australia - English - Department of Health (Therapeutic Goods Administration)

life healthcare pty ltd - 48088 - humeral head prosthesis - composed of tial6v4. an all extraosseous part that has a sand blasted surface & provides a silver coating applied circumferentially. uses the cylindrical fit & serration connection for attachment to the connecting part, extension piece & a femoral stem. six holes at the proximal part of the head are used for securing a pet mesh soft tissue attachment tube. the thread at the proximal part serves for connecting with the mutars humerus cap and mutars humerus cap inverse respectively. a component of the mutars system intended to replace the humeral head as part of a proximal or total humerus reconstruction. primary indication for the use of the mutars systems is after bone resection because of a tumour. further indications for the use of the mutars systems are massive bone loss such as in morbus gorham or for the revision arthroplasty and for the prosthetic treatment in case of fractures, pseudarthrosis and arthrosis. the silver coated surface builds a long term prophylaxis against the colonisation of human pathogenic bacteria such as staphylococcus aureus and epidermis, exclusive enterobacteriae and should not be considered as acute treatment.

Australia - English - Department of Health (Therapeutic Goods Administration)

life healthcare pty ltd - 16082 - prosthesis, internal, bone, cap - composed of tial6v4. designed with the mutars cylindrical fit and serration (36 teeth) connection for attachment to the mutars humerus extension piece, humerus reducer piece or humerus connecting part to achieve a functional length adjustment to the stump terminus. it has a sand blasted surface finish and the cap provides a silver coating. a component of the mutars system intended to be used in rare cases of bone tumors and bone metastases in which no full extremity preserving surgery can be carried out to prosthetically preserve a terminal humeral stump. primary indication for the use of the mutars systems is after bone resection because of a tumour. further indications for the use of the mutars systems are massive bone loss such as in morbus gorham or for the revision arthroplasty and for the prosthetic treatment in case of fractures, pseudarthrosis and arthrosis. the silver coated surface builds a long term prophylaxis against the colonisation of human pathogenic bacteria such as staphylococcus aureus and epidermis, exclusive enterobacteriae and should not be considered as acute treatment.

Australia - English - Department of Health (Therapeutic Goods Administration)

life healthcare pty ltd - 58084 - diaphysis prosthesis - composed of tial6v4 with silver coating. it consists of 2 parts: the humerus connecting part distal & connecting part proximal. the two parts connect with the humerus screw for connecting part. the stem is straight & has a hexagonal cross section for rotational stability. one cross hole ?4 mm for optional cortical screw for extra stability. uses cylindrical fit connection to attach to humeral stems or extension pieces. 2 retention rings for securing pet mesh soft tissue attachment tube. a component of the mutars system intended for bridging bone defects in the humeral diaphyseal area. primary indication for the use of the mutars systems is after bone resection because of a tumour. further indications for the use of the mutars systems are massive bone loss such as in morbus gorham or for the revision arthroplasty and for the prosthetic treatment in case of fractures, pseudarthrosis and arthrosis. intended to be used with bone cement. the silver coated surface builds a long term prophylaxis against the colonisation of human pathogenic bacteria such as staphylococcus aureus and epidermis, exclusive enterobacteriae and should not be considered as acute treatment.

Australia - English - Department of Health (Therapeutic Goods Administration)

life healthcare pty ltd - 61006 - humeral stem extension prosthesis - composed of tial6v4 with silver coating. the connection piece consists of two parts: the mutars connecting part distal & connecting part proximal. the two parts are connected with the mutars screw for connecting part. uses the mutars cylindrical fit & serration connection for attachment to the mutars humerus head, reducer piece, connecting part, end piece, stem, distal humerus & proximal ulna. the connecting part has 1 retention ring for securing a pet mesh soft tissue attachment tube. a component of the mutars system intended as an extraosseous length adjustment in the area of the humerus for the bridging of bone defects. primary indication for the use of the mutars systems is after bone resection because of a tumour. further indications for the use of the mutars systems are massive bone loss such as in morbus gorham or for the revision arthroplasty and for the prosthetic treatment in case of fractures, pseudarthrosis and arthrosis. the silver coated surface builds a long term prophylaxis against the colonisation of human pathogenic bacteria such as staphylococcus aureus and epidermis, exclusive enterobacteriae and should not be considered as acute treatment.

Australia - English - Department of Health (Therapeutic Goods Administration)

life healthcare pty ltd - 48067 - knee wedge - composed of tial6v4 with silver coating on outer contour. connected to the distal part of the condyles of the mutars genux femur cemented using femoral spacer screws. spacers are available for left lateral/right medial & right lateral/left medial applications. can only be used with a cemented femoral component of the same size. surfaces of spacers are sandblasted & 0.7 mm deep cement pockets provided to augment cement fixation. bore holes are provided for the 6.5 mm spacer attachment screws. a component of the mutars system intended to be used for bridging bone defects on the distal medial and lateral aspects of the distal femur. primary indication for the use of the mutars systems is after bone resection because of a tumour. further indications for the use of the mutars systems are massive bone loss such as in morbus gorham or for the revision arthroplasty and for the prosthetic treatment in case of fractures, pseudarthrosis and arthrosis. the silver coated surface builds a long term prophylaxis against the colonisation of human pathogenic bacteria such as staphylococcus aureus and epidermis, exclusive enterobacteriae and should not be considered as acute treatment.

Australia - English - Department of Health (Therapeutic Goods Administration)

life healthcare pty ltd - 61561 - body femoral/tibial extension stem, uncoated - composed of tial6v4 alloy with silver coating. uses the mutars cylindrical fit and serration connection design for attachment to the proximal or distal femur component or the proximal tibia component and a femoral or tibial stem or other components. the extension piece has retention rings for securing a pet mesh soft tissue attachment tube component. a component of the mutars system intended to be used as an extraosseus length adjustment in the area of the proximal or distal femur or proximal tibia. primary indication for the use of the mutars systems is after bone resection because of a tumour. further indications for the use of the mutars systems are massive bone loss such as in morbus gorham or for the revision arthroplasty and for the prosthetic treatment in case of fractures, pseudarthrosis and arthrosis. the silver coated surface builds a long term prophylaxis against the colonisation of human pathogenic bacteria such as staphylococcus aureus and epidermis, exclusive enterobacteriae and should not be considered as acute treatment.

Australia - English - Department of Health (Therapeutic Goods Administration)

life healthcare pty ltd - 16082 - prosthesis, internal, bone, cap - composed of tial6v4 with silver coating. designed with the mutars cylindrical fit and serration connection for attachment to the proximal tibia replacement (or distal femur replacement) component or with a mutars extension piece to achieve a functional length adjustment to the stump terminus. it has a sand blasted surface finish and the cap provides a silver coating. a component of the mutars system intended to be used in rare cases of bone tumors and bone metastases in which no full extremity preserving surgery can be carried out, to prosthetically preserve a terminal femoral or tibial stump. primary indication for the use of the mutars systems is after bone resection because of a tumour. further indications for the use of the mutars systems are massive bone loss such as in morbus gorham or for the revision arthroplasty and for the prosthetic treatment in case of fractures, pseudarthrosis and arthrosis. the silver coated surface builds a long term prophylaxis against the colonisation of human pathogenic bacteria such as staphylococcus aureus and epidermis, exclusive enterobacteriae and should not be considered as acute treatment.

Australia - English - Department of Health (Therapeutic Goods Administration)

life healthcare pty ltd - 40124 - hinged total elbow prosthesis - composed of tial6v4 with silver coating. consists of 3 parts: the distal humerus component, cocrmo distal humerus bushing and axle. the bushings are laterally pressed into the distal humerus and the bushings serve as the articulating component for the hinge mechanism (axle). the distal humerus is an all extraosseous part. uses cylindrical fit and serration connection for attachment to various components. has a retention ring for securing a pet mesh soft tissue attachment tube component. a component of the mutars system intended to replace the distal part of the humerus. primary indication for the use of the mutars systems is after bone resection because of a tumour. further indications for the use of the mutars systems are massive bone loss such as in morbus gorham or for the revision arthroplasty and for the prosthetic treatment in case of fractures, pseudarthrosis and arthrosis. the silver coated surface builds a long term prophylaxis against the colonisation of human pathogenic bacteria such as staphylococcus aureus and epidermis, exclusive enterobacteriae and should not be considered as acute treatment.

Australia - English - Department of Health (Therapeutic Goods Administration)

life healthcare pty ltd - 32831 - uncoated knee femur prosthesis - composed of cocrmo with silver coating & tin coating. articulates with a tibial bearing insert attached to a tibial plateau or proximal tibia. includes section that replaces the bone of the distal femoral shaft. designed with medial & lateral voids filled with tial6v4 metal plugs. 5? tilt between rotation & femoral axis to match anatomical characteristics. uses cylindrical fit connection for attachment of a femoral stem retention ring for fixation of a pet mesh soft tissue attachment tube. a component of the mutars system intended to replace the entire distal femur. primary indication for the use of the mutars systems is after bone resection because of a tumour. further indications for the use of the mutars systems are massive bone loss such as in morbus gorham or for the revision arthroplasty and for the prosthetic treatment in case of fractures, pseudarthrosis and arthrosis. the silver coated surface builds a long term prophylaxis against the colonisation of human pathogenic bacteria such as staphylococcus aureus and epidermis,exclusive enterobacteriae and should not be considered as acute treatment.

Australia - English - Department of Health (Therapeutic Goods Administration)

life healthcare pty ltd - 32831 - uncoated knee femur prosthesis - composed of cocrmo with silver anti-infective coating. articulates with a tibial bearing insert attached to a tibial plateau or proximal tibia. includes section that replaces the bone of the distal femoral shaft. designed with medial & lateral voids filled with tial6v4 metal plugs. 5? tilt between rotation & femoral axis to match anatomical characteristics. uses cylindrical fit connection for attachment of a femoral stem retention ring for fixation of a pet mesh soft tissue attachment tube. a component of the mutars system intended to replace the entire distal femur, primary indication for the use of the mutars systems is after bone resection because of a tumour. further indications for the use of the mutars systems are massive bone loss such as in morbus gorham or for the revision arthroplasty and for the prosthetic treatment in case of fractures, pseudarthrosis and arthrosis. the silver coated surface builds a long term prophylaxis against the colonisation of human pathogenic bacteria such as staphylococcus aureus and epidermis,exclusive enterobacteriae and should not be considered as acute treatment.